Wednesday, March 09, 2022 11:00:36 PM
JJ probably felt that the current EUA application has some weaknesses, and rather than WAIT for potential rejection....include the BTD to improve the odds of success. That's my guess.
I feel that the bigger story for RLFTF (over the short-term), and one that has higher odds for success, is the June 5, 2022 PDUFA event. With full FDA approval for ACER-001 (to treat Urea Cycle Disorders), that paves the way for new revenues for RLFTF. We could see a pps boost if all goes well with that initiative.
https://www.acertx.com/2021/10/06/acer-therapeutics-and-relief-therapeutics-announce-fda-acceptance-for-filing-of-new-drug-application-for-acer-001-to-treat-urea-cycle-disorders/
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM